NCT04876781
- Conditions
- Active Ankylosing Spondylitis, Active Moderate to Severe Rheumatoid Arthritis, Active Psoriatic Arthritis
- Locations
-
- Pfizer Seoul, South Korea
Clinical trial condition
Active Psoriatic Arthritis
Explore clinical trials studying Active Psoriatic Arthritis. Study availability and eligibility vary by location and protocol.
6 public trials
1 recruiting study
Active Psoriatic Arthritis trial results
NCT04314544
- Conditions
- Active Psoriatic Arthritis
- Locations
-
- Sunpharma Site no 42 Dothan, Alabama, United States
- Sunpharma Site no 29 Gilbert, Arizona, United States
- Sunpharma Site no 30 Glendale, Arizona, United States
- Sunpharma Site no 31 Mesa, Arizona, United States
Completed
Efficacy and Safety Study of SUNPG1623
NCT02980692
- Conditions
- Active Psoriatic Arthritis
- Locations
-
- SPARC Site 1 Middleburg Heights, Ohio, United States
NCT03881059
- Conditions
- Active Psoriatic Arthritis
- Locations
-
- Rheumatology Associates of North Alabama Huntsville, Alabama, United States
- Medvin Clinical Research - Covina Office Covina, California, United States
- University of California at San Diego Medical Center La Jolla, California, United States
- Arthritis & Rheumatic Disease Specialties Aventura, Florida, United States
- Conditions
- Active Ankylosing Spondylitis, Active Psoriatic Arthritis, Hemic and Lymphatic Diseases, +11 more
- Locations
-
- Ra0098 116 Mesa, Arizona, United States
- Ra0098 107 Mesa, Arizona, United States
- Ra0098 135 Phoenix, Arizona, United States
- Ra0098 119 Tucson, Arizona, United States
Active, Not Recruiting
Efficacy and Safety of Tildrakizumab Compared to Placebo in Anti-TNF naïve Subjects With Active Psoriatic Arthritis II (INSPIRE 2)
NCT04314531
- Conditions
- Active Psoriatic Arthritis
- Locations
-
- Sunpharma site no. 12 Covina, California, United States
- Sunpharma site no. 04 Miami Beach, Florida, United States
- Sunpharma site no. 02 New Port Richey, Florida, United States
- Sunpharma site no. 07 Tamarac, Florida, United States